Vivo Opportunity Fund, L.P.'s Net Worth

$0

Estimate Recalculated Sep 17, 2024 11:50PM EST

Who is Vivo Opportunity Fund, L.P.

Vivo Opportunity Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., Bolt Biotherapeutics, Inc., and Terns Pharmaceuticals, Inc..

SEC CIK

Vivo Opportunity Fund, L.P.'s CIK is 0001726403

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Crinetics Pharmaceuticals, Inc.

Investor
Updated Mar 11, 2020
Form 4
-0.02%
-528.00
$19.50
-$10.30K
Mar 11, 2020
3.27M
Sale
Mar 09
Form 4
-0.21%
-13.46K
$21.70
-$291.59K
Feb 11, 2020
6.54M
Sale
Feb 07 - Feb 10
Form 4
-0.41%
-13.46K
$22.80
-$306.89K
Feb 06, 2020
3.28M
Sale
Feb 04
Form 4
-0.27%
-26.92K
$22.00
-$594.16K
Jan 31, 2020
9.90M
Sale
Jan 29 - Jan 31
Form 4
-11.16%
-417.00K
$22.25
-$9.28M
Mar 25, 2019
3.32M
Sale
Mar 20
Form 4
-42.43%
-7.40M
$17.65
$6.58M
Jul 20, 2018
10.04M
Buy-Options
Jul 20
Showing 6 results

Kadmon Holdings, Inc.

Investor
Updated Jan 08, 2019
Form 3
Jan 08, 2019
12.61M
Showing 1 results

Bolt Biotherapeutics, Inc.

Investor
Updated Feb 09, 2021
Form 4
9.93%
349.77K
$16.57
$3.00M
Feb 09, 2021
3.87M
Purchase
Feb 09
Showing 1 results

Terns Pharmaceuticals, Inc.

Investor
Updated Feb 09, 2021
Form 4
118.18%
1.45M
$17.00
$6.08M
Feb 09, 2021
2.68M
Purchase
Feb 09
Showing 1 results

Sierra Oncology, Inc.

Investor
Updated Jan 31, 2022
Form 4
41.33%
800.00K
$27.00
$21.60M
Jan 31, 2022
3.33M
Purchase
Jan 31
Form 4
-32.96%
-1.24M
$13.20
-$16.41M
Jan 28, 2022
2.53M
Options
Jan 26
Form 4
2,143.35%
1.83M
Jan 31, 2020
1.92M
Options
Jan 29
Form 3
Dec 02, 2019
2.44M
Showing 4 results

ALX ONCOLOGY HOLDINGS INC

Investor
Updated Jul 21, 2020
Form 4
33.59%
1.06M
$19.00
$3.52M
Jul 21, 2020
4.22M
Purchase
Jul 21
Showing 1 results